WO1993017741A1 - Nitric oxide from air for medical uses - Google Patents
Nitric oxide from air for medical uses Download PDFInfo
- Publication number
- WO1993017741A1 WO1993017741A1 PCT/US1993/002518 US9302518W WO9317741A1 WO 1993017741 A1 WO1993017741 A1 WO 1993017741A1 US 9302518 W US9302518 W US 9302518W WO 9317741 A1 WO9317741 A1 WO 9317741A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- air
- mixture
- nitric oxide
- arc chamber
- inhaler
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/34—Chemical or biological purification of waste gases
- B01D53/46—Removing components of defined structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0013—Details of inhalators; Constructional features thereof with inhalation check valves
- A61M15/0016—Details of inhalators; Constructional features thereof with inhalation check valves located downstream of the dispenser, i.e. traversed by the product
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/34—Chemical or biological purification of waste gases
- B01D53/46—Removing components of defined structure
- B01D53/54—Nitrogen compounds
- B01D53/56—Nitrogen oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
Definitions
- This invention relates to a method and a system for producing nitric oxide mixed with air or other gases for use in medicine.
- Nitric oxide (NO) is crucial to many biological systems (G. Kolada, The New York Times, July 2, 1991, p. Cl.)- Kolada indicates that nitric oxide mediates the control of blood pressure, helps the immune system kill invading parasites that enter cells, stops cancer cells from dividing, transmits signals between brain cells, and contributes to the large scale death of brain cells that can debilitate people with strokes or Huntington's disease.
- Smooth muscle is present, for example, in the walls of the blood vessels, bronchi, gastrointestinal tract, and urogenital tract.
- Administration of nitric oxide gas to the lung by inhalation could produce localized smooth muscle relaxation without systemic side effects. This characteristic can be used in medicine to treat bronchial constriction and pulmonary hypertension, pneumonia, etc.
- Nitric oxide is now known to be an important naturally occurring local cellular hormone, the so-called endothelium derived relaxing factor.
- This factor is produced in many cells (i.e., endothelial cells lining blood vessels, bronchi, intestines, bladder, uterus, and other hollow organs) by the enzyme nitric oxide synthetase (now known to be a family of at least six enzymes) from arginine. Once NO is released, it binds rapidly to the enzyme guanylate cyclase in smooth muscle cells, increasing cyclic guanylate monophosphate (cyclic GMP) , reducing intracellular calcium levels and thereby causing smooth muscle relaxation.
- nitric oxide synthetase now known to be a family of at least six enzymes
- Bronchodilators are drugs which are used to reduce airway reactivity and to reverse bronchospasm caused by a variety of diseases, such as asthma, exacerbations of chronic pulmonary obstructive disease, allergic and anaphylactic reactions and others.
- Several classes of bronchodilators have been employed, each with its own mode of action, tolerance and undesirable side effects.
- Beta agonists represented by epinephrine and isoproterenol, induce bronchodilation by stimulating receptors that increase adenyl cyclase concentrations and the production of intracellular cyclic adenosine monophosphate (AMP) . They can be delivered by aerosol, orally or parenterally.
- AMP intracellular cyclic adenosine monophosphate
- Theophylline preparations are less potent bronchodilators than beta agonists and have a narrower therapeutic toxic window.
- the mechanism responsible for the bronchodilator effect of theophylline is probably via cyclic AMP.
- Side effects commonly caused by theophylline are nervousness, nausea, vomiting, anorexia and headache. Furthermore, if taken at very high levels, theophylline can cause cardiac arrhythmias and seizures.
- Nitric oxide is unique in that it combines a rapid onset of action occurring within seconds with the absence of systemic effects. Once inhaled, it diffuses through the pulmonary vasculature into the bloodstream, where it is rapidly inactivated by combination with hemoglobin. Therefore, the bronchodilator effects of inhaled nitric oxide are limited to the airway and the vasodilatory effects of inhaled nitric oxide are limited to the pulmonary vasculature.
- Pulmonary hypertension is defined as an elevation of the mean pulmonary arterial pressure over the normal levels of 12 to 15 millimeters Hg.
- vasodilator drugs including nitroprusside, hydralazine, nifedipine, captopril and others.
- Major limitation of these agents has been their non-selective reduction of both pulmonary and systemic blood pressures.
- inhaled nitric oxide produces vasodilation limited to pulmonary vessels and thus offers a revolutionary therapeutic advantage.
- the present invention is a system for producing a mixture of nitric oxide and air or other gases for use in medicine.
- the system generates nitric oxide in an electric arc discharge using only air and a source of electricity.
- the invention enables unlimited production of nitric oxide at any location.
- a patient can carry a portable inhaler version of the invented system anywhere he or she goes and use the inhaler for treatment of asthma attacks or other forms of bronchoconstriction, of acute respiratory failure, or reversible pulmonary vasoconstriction. Furthermore, the patient can vary the inhaled amount of NO as his or her medical condition changes.
- the invention system can be used in medical or urgent care facilities for generating NO and delivering a therapeutically-effective concentration of NO mixed with other gases to a specific organ of a human body. Nitric oxide relaxes smooth muscles almost immediately after delivery; moreover, the action of nitric oxide is limited only to the organ subjected to the treatment.
- the invention is an inhaler producing a mixture of air or other gases and nitric oxide for respiratory therapy; the inhaler utilizes a source of electricity to generate an electric arc across a pair of electrodes separated by an air gap. Air is continuously introduced through an air input port to an electric arc chamber which contains the electrodes.
- the inhaler has an electric circuit for supplying a high voltage potential to the electrodes, wherein the high voltage potential has a peak value sufficient to induce the electric arc across the air gap.
- the arc discharge produces nitric oxide.
- the produced nitric oxide mixed with air is dispensed through an output port and is inhaled by a patient.
- Preferred embodiments of this aspect of the invention may include electrodes made of two axially aligned metal rods with their tips separated by an adjustable air gap placed in the arc chamber.
- the circuitry of the inhaler comprises a high voltage transformer with the primary coil connected to an electric power supply, and a parallel RCL circuit connected in parallel to the secondary, high voltage coil of the transformer.
- the resistive element of the parallel RCL circuit comprises the high voltage electrodes separated by the air gap.
- the air input port of the inhaler has a filter for filtering introduced air through the input port to prevent liquid droplets or solid particles from entering the arc chamber.
- the inhaler is of a hand-held size and weighs less than approximately 1 kg.
- Preferred embodiments of this aspect of the invention may also include a purifying device for removing the low levels of nitrogen dioxide and ozone produced in the arc chamber.
- the purifying device is located so that gas leaving the arc chamber is forced through the purifying device before it is released from the inhaler.
- the output port also has a mouthpiece for directly inhaling the gas mixture from the arc chamber forced through the purifying device.
- Preferred embodiments of this aspect of the invention may also include an air input assembly with a set of selective restricting orifices for introducing a controlled amount of air to the inhaling port and blending the air with the gas mixture from the arc chamber while inhaling the mixture though the mouthpiece.
- the purifying device contains a scavenger for 0 3 and N0 2 , such as sodalime or baralime.
- Preferred embodiments of this aspect of the invention may also include a gas pump for forcing the gas mixture through the purifying device out the output port.
- the gas mixture then enters an oxygen mask or is forced into a room or chamber, such as an incubator.
- the invention is a system for continuously producing a mixture of air and nitric oxide for treatment of medical conditions requiring direct delivery of this mixture to an organ of the human body.
- the system has an electric arc chamber with a pair of electrodes separated by an air gap, for producing nitric oxide by arc discharge between the electrodes.
- the system also has an electric circuit for supplying a high voltage potential to the electrodes.
- the high voltage potential has a peak value sufficient to induce an electric arc across the air gap.
- An air input port of the system is used for continuously introducing air into the electric arc chamber.
- a gas delivery system is used for purifying and dispensing the produced nitric oxide mixed with air or other gases to an organ of the human body, for example, administering the mixture (to which other gases, e.g., anesthesia could be added) to the lung using a mechanical ventilator or respirator.
- FIG. 1 is a diagrammatic cross-sectional view of a portable inhaler embodiment of the invention.
- FIG. 2 shows a schematic diagram of a high voltage generating circuit for embodiments.
- FIG. 3 is a diagrammatic cross-sectional view of a larger inhaler embodiment for use at home.
- FIG. 4 is a diagrammatic cross-sectional view of an inhaler system embodiment for use in medical and urgent care facilities.
- FIG. 5 is a diagrammatic cross-sectional view of another embodiment, for delivering nitric oxide to different organs of a human body, including a mechanical ventilator for respiratory support.
- FIG. 6 is a graph depicting the dependence of effluent gas nitric oxide concentration on the average current in the primary coil of the high voltage transformer and the flow rate of air through the arc chamber, for a 3 mm gap between the electrodes, where V is air flow rate in liters/minute, and the NO level is in parts per million volume (ppm) .
- FIG. 7 is a graph depicting the dependence of effluent gas nitric oxide concentration on the current in the primary coil of the high voltage transformer and the flow of air through the arc chamber, for a 5 mm gap between the electrodes, where V is air flow in liters/minute, and the NO level is in parts per million volume (ppm) .
- FIG. 8 is a graph depicting the dependence of the pulmonary arterial pressure during different stages of an NO inhalation trial on an awake sheep with acute pulmonary hypertension due to infusion of U46619.
- the NO gas was produced by electric discharge, and shows marked pulmonary vasodilatory properties.
- Shown in FIG. 1 is a portable inhaler with an input port 2 for introducing air into an electric arc chamber 4.
- Input port 2 contains a one way valve and a 0.22 micron filter 3 made by Millipore Corp. The filter removes bacteria and undesirable constituents present in the introduced air.
- Arc chamber 4, made of an electrically insulating material, has two axially positioned electrodes 5 separated by an air gap 9.
- a high voltage generating circuit 7 is connected to the electrodes 5.
- Electric arc chamber 4 is coupled to a sodalime filter 13 which is attached to an inhaling port 14.
- Inhaling port 14 has a mouthpiece 17 and an air input assembly 15 comprised of a set of selectable restricting orifices. Each orifice has a filter 16 for filtering liquid droplets and solid particles present in the air.
- the gas passage system (including input port 2, filters 3, 13, 16, and inhaling port 14) is designed to allow easy, relatively unrestricted inhalation by the patient. Different types of filters 3, 16 can be employed according to the environmental conditions in which the inhaler is used.
- the inhaler is enclosed in a case 19 made of Teflon® or another high voltage insulator.
- a power switch 11 with a pilot light 12 controls operation of the inhaler.
- a high voltage generating circuit 7 consists of a step up transformer 24 with primary and secondary coils.
- the primary coil is connected to a power supply 21, and secondary, high voltage coil 25 is connected to a parallel RCL circuit.
- Voltage from power supply 21 is regulated by a variac 23 and transformed to higher values in a secondary coil 25.
- Other circuits for generating high energy voltages such as a Tesla coil, could also be used.
- the electric energy is temporarily stored in a capacitor 26 which is charged up to breakdown voltage and subsequently discharged across air gap 9.
- Air gap 9 defined by two electrodes 5 determines the resistance of the two electrode arrangement.
- the breakdown voltage ( «20kV) is proportional to the width of the air gap and the shape of electrodes 5.
- the electric arc discharge produces plasma localized across the air gap.
- molecules of oxygen and nitrogen are broken and the atoms ionized to form ozone and nitric oxide.
- a small fraction of nitric oxide then oxidizes to a higher oxidation state and forms nitrogen dioxide (N0 2 ) .
- N0 2 nitrogen dioxide
- concentrations of NO, N0 2 and 0 3 vary depending upon the width of the air gap and the duration of the electric arc, and are expressed as parts per million by volume (ppm) .
- the gases are drawn out from arc chamber 4, through sodalime filter 13, and out of inhaling port 16 by a patient inhaling the gas mixture through mouthpiece 17.
- Sodalime filter 13 removes toxic N0 2 and 0 3 from the gas mixture preventing them from reaching the inhaling port, so that it contains primarily air and NO.
- additional air enters the inhaler through input port 2 and is drawn into arc chamber 4.
- Subsequent arc discharges ionize the N 2 and 0 2 molecules which form NO, N0 2 , and 0 3 , and the process is repeated.
- the concentration of NO produced in the arc discharge chamber varies from 10 to 250 ppm depending on the resistance of air gap 9 and the power delivered to electrodes 5.
- the therapeutically beneficial range of NO concentration is from about 1 ppm to 180 ppm.
- an additional air admixing input port 15 with a set of openings of different sizes is used as an air intake port.
- a patient breathing in the gases from the inhaler through the mouthpiece 17 automatically mixes the gases from the arc chamber with air entering input port 15.
- the patient can select a different size of the orifice in order to increase or decrease the amount of air drawn into inhaling port 16 through air input port 15..
- a gas pump 18, or other pressure source e.g., ventilator
- inhaling port 16 to force the gas mixture out of the inhaler.
- the mouthpiece could then be attached to an endotracheal tube or tracheostomy tube.
- This electrical NO generator can be attached to a standard gas powered multidose inhaler (MDi) , which ejects a chemical bronchodilator (e.g., terbutaline, corticosteroid, etc.) into port 15. Following several seconds inhaling electrically produced NO to produce immediate bronchodilation, the MDi is activated to produce longer duration bronchodilation.
- MDi gas powered multidose inhaler
- the inhaler is a portable lightweight hand-held battery powered unit of less than approximately 20 x 20 x 10 cm in size.
- a patient suffering from asthma or pulmonary hypertension can carry the inhaler, and use it according to his or her needs. Initially, the patient might need to inhale larger doses of nitric oxide, for example, in a concentration of 150 ppm of nitric oxide in air; this can be done by closing air input port 15. As the patient's bronchi and/or pulmonary vessels dilate, he or she can decrease this concentration by choosing a larger orifice.
- the hand-held inhaler provides an unlimited supply of NO.
- the inhaler is a larger system for use at home. Referring to FIG.
- an air pump 32 forces air to an electric arc chamber 35.
- a filter 31 located at an input port 30 removes undesirable constituents present in the introduced air.
- the arc chamber made of an electrically insulating material has two electrodes 36 separated by an air gap. Electrodes 36 are connected to a high voltage circuit 34 powered by a standard 110V, 60Hz (or 220V, 50Hz) outlet. Nitric oxide, nitrogen dioxide, and ozone produced in the arc discharge are forced through a sodalime filter 38. Filter 38 absorbs N0 2 and 0 3 from the gas mixture. Nitric oxide mixed with air or other gases (e.g. 0 2 ) is pumped out of an output port 39 which can be connected to a face mask. In another preferred embodiment, the produced gas mixture is pumped into an incubator or a room through output port 39.
- the inhaler is a unit used in medical and urgent care facilities. Size of the inhaler depends on the particular use. A large unit is powered by a standard 110V, 60Hz power outlet, and a portable unit by a 9V battery.
- an air tank and regulator 40 is utilized to supply air pressurized at 17 psi to the NO generation system.
- the system has an input port 42, an arc chamber 44 with electrodes 46, and a sodalime filter 48. The mixture of NO and air is generated in the same way as discussed earlier.
- this system has a five liter mixing bag 50 connected to an output port 58.
- Mixing bag 50 is used to blend air supplied through a port 54 and oxygen or oxygen rich N 2 mixture supplied through a port 52.
- the mixture of air, oxygen, and NO is introduced through the output port 58 to a ventilator or to an oxygen mask.
- An inspired oxygen fraction (Fi0 2 ) meter 56 is attached to output port 58 to measure the proportion of 0 gas, by volume.
- the invention is a system used in medical facilities such as an intensive care unit or emergency room.
- a source 60 of air pressurized near 50 psi is used in this system.
- the arc chamber of this larger unit could contain more than one pair of electrodes in order to increase the amount of produced nitric oxide.
- the arrangement of this unit is similar to the one shown in FIGS. 1, 3 and 4.
- the pressurized air is introduced through a regulator 62 to an arc chamber 64 where electrodes 66 are located.
- a sodalime filter 68 absorbs the unwanted by-products of the arc discharge process (i.e. N0 2 and 0 3 ) .
- the mixture of air and NO is blended by a Bird blender 70 with oxygen supplied through a port 72.
- An Fi0 2 meter 74 attached to an output port 76 measures the 0 2 proportion.
- the system is powered by a standard 110V, 60Hz power source.
- the unit can have an automatic regulator system and a gas analyzer connected to the air intake port and to the gas pump.
- the gas analyzer monitors the amounts of nitric oxide and other gases in the mixture of gases delivered to an organ of a human body; in addition, the analyzer manages the automatic regulator system in order to maintain a specific concentration of nitric oxide according to a predetermined scheme.
- This embodiment could be attached to a mechanical ventilator and used to provide NO gas mixtures for ventilatory therapy. Different attachments (not shown in FIG.
- Example 1 Performance of a test unit is shown in FIGS. 6 and 7 for 3 mm and 5 mm gaps between the electrodes, respectively.
- Different flow levels (V) of air in the range from 1 liter/minute (1/m) to 10 1/m are introduced into the arc chamber.
- Current in the primary coil of the high voltage transformer is varied from 250/iA to 1.25mA in order to increase the power supplied to the high voltage generating circuit.
- the output from the arc chamber is drawn into a N0 X chemiluminescence gas analyzer in order to establish the concentrations of the different oxides of nitrogen.
- the concentration of NO expressed in parts per million, increases monotonically with power supplied to the electrodes, which have 3 mm separation.
- the highest concentration of nitric oxide is obtained for an air flow (V) of 1 1/m; further increase in the flow rate of air decreases NO concentration.
- the ozone level produced in the electric arc discharge was measured by an ultraviolet photometric ozone analyzer.
- the NO generation system with a spark gap of 3mm at a 2 1/m air flow rate produced 0.01 ppm of ozone in the arc discharge chamber.
- This 0 3 level is substantially below the ozone exposure limit established by the U.S. Department of Labor, the Occupational Safety and Health Administration.
- the N0 2 levels were similarly measured at very low levels ( ⁇ 2% of NO levels) .
- the optimal operating regime is around 1.1mA with the air flow of about 1.5 1/m.
- these parameters are dependent on the shape of the electrodes, humidity of air and other factors.
- Example 2 A 30 kg male Dorset sheep with a tracheostomy was instrumented with a 7 Fr pulmonary artery Swan-Ganz catheter and femoral arterial line for constantly monitoring pulmonary and systemic arterial pressures.
- the awake sheep was given a continuous infusion of 0.6 ⁇ g/kg/min of U46619 (Upjohn Pharmaceuticals) , a stable thromboxane analog capable of producing acute pulmonary vasoconstriction and hypertension.
- the infusion of U46619 caused the pulmonary arterial pressure (PAP) to increase 79% from the mean baseline value of 19 mm Hg to 33 mm Hg.
- An electric arc and circuit similar to figure 4 was used to generate a mixture of air and NO.
- FIG. 8 shows the dependence of the mean PAP on different levels of inhaled NO measured continuously by chemiluminescence.
- the PAP decreased to a level of 23 mm Hg. Additional increase of the inhaled NO to 40 ppm further reduced the PAP to its baseline level without U46619 infusion of 18 mm Hg.
- air in the claims, it is also intended to include ordinary air as well as other mixtures of gas comprising N 2 and 0 2 .
- gases e.g., anesthetics, additional 0 2 , other bronchodilating drugs (e.g., multidose inhalers), or other drugs for pulmonary therapy (e.g., surfactants, mucolytics, anti-inflammatory agents) , etc.
- drugs for pulmonary therapy e.g., surfactants, mucolytics, anti-inflammatory agents
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Environmental & Geological Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Respiratory Apparatuses And Protective Means (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Oxygen, Ozone, And Oxides In General (AREA)
- Treating Waste Gases (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69333015T DE69333015T2 (en) | 1992-03-11 | 1993-03-08 | GENERATION OF NITROGEN OXIDE FROM AIR FOR MEDICAL USE |
BR9306060A BR9306060A (en) | 1992-03-11 | 1993-03-08 | Nitrous oxide of air for medical uses |
AU39250/93A AU3925093A (en) | 1992-03-11 | 1993-03-08 | Nitric oxide from air for medical uses |
CA002117691A CA2117691C (en) | 1992-03-11 | 1993-03-08 | Nitric oxide from air for medical uses |
AT93908422T ATE242022T1 (en) | 1992-03-11 | 1993-03-08 | GENERATION OF NITROGEN OXIDE FROM AIR FOR MEDICAL USE |
EP93908422A EP0630270B1 (en) | 1992-03-11 | 1993-03-08 | Nitric oxide from air for medical uses |
JP51606693A JP3573455B2 (en) | 1992-03-11 | 1993-03-08 | Medical nitric oxide obtained from air |
DK93908422T DK0630270T3 (en) | 1992-03-11 | 1993-03-08 | Nitric oxide from the air for medical applications |
NO19943349A NO310961B1 (en) | 1992-03-11 | 1994-09-09 | Inhalator which produces a mixture of air and nitric oxide for respiratory therapy, as well as system and method for this production |
FI944170A FI110922B (en) | 1992-03-11 | 1994-09-09 | Nitric oxide from air for medical purposes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US850,383 | 1992-03-11 | ||
US07/850,383 US5396882A (en) | 1992-03-11 | 1992-03-11 | Generation of nitric oxide from air for medical uses |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993017741A1 true WO1993017741A1 (en) | 1993-09-16 |
Family
ID=25307968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/002518 WO1993017741A1 (en) | 1992-03-11 | 1993-03-08 | Nitric oxide from air for medical uses |
Country Status (16)
Country | Link |
---|---|
US (1) | US5396882A (en) |
EP (1) | EP0630270B1 (en) |
JP (2) | JP3573455B2 (en) |
AT (1) | ATE242022T1 (en) |
AU (1) | AU3925093A (en) |
BR (1) | BR9306060A (en) |
CA (1) | CA2117691C (en) |
DE (1) | DE69333015T2 (en) |
DK (1) | DK0630270T3 (en) |
ES (1) | ES2196006T3 (en) |
FI (1) | FI110922B (en) |
MX (1) | MX9301357A (en) |
NO (1) | NO310961B1 (en) |
PT (1) | PT630270E (en) |
TW (1) | TW242117B (en) |
WO (1) | WO1993017741A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2283179A (en) * | 1993-10-12 | 1995-05-03 | Timothy William Higenbottam | Apparatus for nitric oxide treatment |
WO2000030659A1 (en) * | 1998-11-23 | 2000-06-02 | Pulmonox Medical Corporation | Method and apparatus for treatment of respiratory infections by nitric oxide inhalation |
EP1046405B1 (en) * | 1999-04-24 | 2004-06-23 | Klaus Büttner | Aerosol nebulizer |
US6793644B2 (en) | 2000-12-26 | 2004-09-21 | Sensormedics Corporation | Device and method for treatment of surface infections with nitric oxide |
WO2009093169A1 (en) * | 2008-01-22 | 2009-07-30 | Koninklijke Philips Electronics N.V. | Device for the topical delivery of nitric oxide to a skin surface |
US8821828B2 (en) | 2009-12-23 | 2014-09-02 | Koninklijke Philips N.V. | Method for generating nitric oxide |
WO2015066278A1 (en) * | 2013-10-31 | 2015-05-07 | Advanced Plasma Therapies, Inc. | Methods for using nitric oxide in a plasma state to treat medical conditions and diseases |
WO2015191843A1 (en) * | 2014-06-13 | 2015-12-17 | Advanced Plasma Therapies, Inc. | Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals |
US9457049B2 (en) | 2010-09-22 | 2016-10-04 | Konklijke Philips N.V. | Method for generating nitric oxide |
US10780241B2 (en) | 2008-08-21 | 2020-09-22 | Vero Biotech LLC | Devices and methods for minimizing and treating high-altitude sickness |
EP3609509A4 (en) * | 2017-03-31 | 2020-11-25 | The General Hospital Corporation | Systems and methods for a cooled nitric oxide generator |
WO2022265837A1 (en) * | 2021-06-17 | 2022-12-22 | Origin, Inc. | Methods of using a plasma-generated stream of no-containing gas for treatment of a spectrum of medical conditions |
US11607520B2 (en) | 2010-04-26 | 2023-03-21 | Vero Biotech Inc. | Delivery of ultra pure nitric oxide (NO) |
US11951261B2 (en) | 2018-10-25 | 2024-04-09 | Teijin Pharma Limited | Nitric oxide administration device |
Families Citing this family (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE560928T1 (en) * | 1990-12-05 | 1994-09-22 | Gen Hospital Corp | DEVICE FOR TREATING A LIFE CONSTRUCTION AND ASTHMA. |
US5536241A (en) * | 1990-12-05 | 1996-07-16 | The General Hospital Corporation | Methods and devices for relaxing smooth muscle contractions |
US5570683A (en) * | 1990-12-05 | 1996-11-05 | The General Hospital Corporation | Methods and devices for treating pulmonary vasoconstriction and asthma |
US5814666A (en) * | 1992-04-13 | 1998-09-29 | The United States As Represented By The Department Of Health And Human Services | Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents |
FR2695831B1 (en) * | 1992-09-24 | 1994-11-10 | Air Liquide | Installation and method for supplying a gaseous mixture to the respiratory tract of a user. |
US6880554B1 (en) * | 1992-12-22 | 2005-04-19 | Battelle Memorial Institute | Dispensing device |
ATE204491T1 (en) * | 1993-04-17 | 2001-09-15 | Messer Griesheim Austria Ges M | DEVICE FOR THE CONTROLLED ADDITION OF NO TO THE BREATHING AIR OF PATIENTS |
AU7197594A (en) * | 1993-07-06 | 1995-02-06 | Kjell Alving | A system to be used for the determination of no levels in exhaled air and diagnostic methods for disorders related to abnormal no levels |
US6063407A (en) * | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
US5823180A (en) * | 1995-04-03 | 1998-10-20 | The General Hospital Corporation | Methods for treating pulmonary vasoconstriction and asthma |
DE29512163U1 (en) * | 1995-07-28 | 1995-10-19 | Vhg Versandhandelsgesellschaft | Device for ionizing gases |
ES2170186T3 (en) * | 1995-10-13 | 2002-08-01 | Siemens Elema Ab | TRAQUEAL TUBE AND DEVICE FOR VENTILATION SYSTEMS. |
US5873523A (en) * | 1996-02-29 | 1999-02-23 | Yale University | Electrospray employing corona-assisted cone-jet mode |
US5699790A (en) * | 1996-03-21 | 1997-12-23 | Ohmeda Inc. | System for predicting NO2 concentrations |
US5692495A (en) * | 1996-04-02 | 1997-12-02 | The Boc Group, Inc. | Method and apparatus for the production of nitric oxide gas mixture |
US5765548A (en) * | 1996-05-07 | 1998-06-16 | Perry; Bryan J. | Use of nitric oxide in the treatment of exercised induced pulmonary hemorrhaging in equine |
US20020185126A1 (en) | 1997-01-17 | 2002-12-12 | Christian Krebs | Controlled gas-supply system |
CA2225013C (en) | 1997-04-04 | 2006-06-06 | Institut Du N.O. Inc. | Injection system for delivery of a gaseous substance |
US5827420A (en) * | 1997-07-29 | 1998-10-27 | World Precision Instruments, Inc. | Method and apparatus for the generation of nitric oxide |
US6656452B1 (en) | 1997-10-21 | 2003-12-02 | The General Hospital Corporation | Use of inhaled NO as anti-inflammatory agent |
US6109260A (en) * | 1998-02-18 | 2000-08-29 | Datex-Ohmeda, Inc. | Nitric oxide administration device with timed pulse |
DE19823748C2 (en) * | 1998-05-27 | 2000-05-18 | Siemens Ag | Method and device for the plasma chemical production of nitrogen monoxide |
US20070086954A1 (en) * | 1998-11-23 | 2007-04-19 | Miller Christopher C | Method and apparatus for treatment of respiratory infections by nitric oxide inhalation |
US6694969B1 (en) * | 1999-09-22 | 2004-02-24 | Instrumentarium Corp. | Method to improve oxygenation in subjects suffering impaired oxygenation |
US7516742B2 (en) * | 1999-11-24 | 2009-04-14 | Cardinal Health 207, Inc. | Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing |
US6758214B2 (en) | 2000-01-28 | 2004-07-06 | Cyterra Corporation | Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment |
US6601580B1 (en) | 2000-06-28 | 2003-08-05 | The General Hospital Corporation | Enhancing therapeutic effectiveness of nitric oxide inhalation |
CA2414941C (en) | 2000-08-11 | 2010-12-14 | David R. Whitlock | Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same |
US7335181B2 (en) * | 2000-12-26 | 2008-02-26 | Pulmonox Technologies Corporation | Nitric oxide decontamination of the upper respiratory tract |
US7122018B2 (en) * | 2000-12-26 | 2006-10-17 | Sensormedics Corporation | Device and method for treatment of wounds with nitric oxide |
RU2183474C1 (en) * | 2001-02-09 | 2002-06-20 | Пекшев Александр Валерьевич | Method and device for producing gas flow containing no for treating biological object |
DE60202677T2 (en) * | 2001-05-25 | 2005-12-29 | Medtronic, Inc., Minneapolis | IMPLANTABLE MEDICAL DEVICE WITH CONTROLLED RELEASE OF GASIFICOUS MEDICINES |
SI1404811T1 (en) | 2001-06-21 | 2009-04-30 | Beth Israel Hospital | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
EP1429829B1 (en) * | 2001-09-05 | 2013-11-27 | Geno LLC | Nitric oxide generation |
GB0125222D0 (en) * | 2001-10-19 | 2001-12-12 | Barts & London Nhs Trust | Composition for the treatment of microbial infections |
CN1308438C (en) * | 2002-01-11 | 2007-04-04 | 大卫·R·怀特洛克 | Compositions including ammonia oxidizing bacteria and methods of using same |
US7531133B2 (en) * | 2002-09-10 | 2009-05-12 | Pulmonox Technologies Corporation | Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma |
US20100170505A1 (en) * | 2002-11-15 | 2010-07-08 | Speight Bryan Barker | Device for enhancing well-being |
WO2005007173A1 (en) * | 2003-07-09 | 2005-01-27 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health | Use of nitrite salts for the treatment of cardiovascular conditions |
US20050255178A1 (en) * | 2004-02-04 | 2005-11-17 | Bloch Kenneth D | Enhancing the effectiveness of an inhaled therapeutic gas |
US8518457B2 (en) * | 2004-05-11 | 2013-08-27 | Pulmonox Technologies Corporation | Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant |
MXPA06013111A (en) | 2004-05-11 | 2007-05-23 | Sensormedics Corp | Intermittent dosing of nitric oxide gas. |
US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
US7560076B2 (en) | 2004-08-18 | 2009-07-14 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
US7618594B2 (en) | 2004-08-18 | 2009-11-17 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
US20070154570A1 (en) * | 2004-09-29 | 2007-07-05 | Miller Christopher C | Use of nitric oxide in the treatment and disinfection of biofilms |
JP4997491B2 (en) * | 2005-03-30 | 2012-08-08 | 国立大学法人 熊本大学 | NO generator |
US8557300B2 (en) * | 2005-05-19 | 2013-10-15 | University Of Cincinnati | Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite |
SE529053C2 (en) * | 2005-07-08 | 2007-04-17 | Plasma Surgical Invest Ltd | Plasma generating device, plasma surgical device and use of a plasma surgical device |
SE529056C2 (en) * | 2005-07-08 | 2007-04-17 | Plasma Surgical Invest Ltd | Plasma generating device, plasma surgical device and use of a plasma surgical device |
SE529058C2 (en) * | 2005-07-08 | 2007-04-17 | Plasma Surgical Invest Ltd | Plasma generating device, plasma surgical device, use of a plasma surgical device and method for forming a plasma |
US20070116785A1 (en) * | 2005-11-18 | 2007-05-24 | Miller Christopher C | Nitric oxide as an anti-viral agent, vaccine and vaccine adjuvant |
US8790715B2 (en) | 2006-02-16 | 2014-07-29 | Ino Therapeutics Llc | Method and apparatus for generating nitric oxide for medical use |
GB0607402D0 (en) * | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
EP3023389B1 (en) | 2006-07-05 | 2020-03-18 | BSN medical GmbH | Device for photolytic production of nitrogen monoxide |
EP2051935B1 (en) | 2006-07-26 | 2016-09-07 | STMicroelectronics Srl | Use of nitroaniline derivatives for the production of nitric oxide |
US8079998B2 (en) * | 2006-10-20 | 2011-12-20 | Pulmonox Technologies Corporation | Methods and devices for the delivery of therapeutic gases including nitric oxide |
KR20090087900A (en) | 2006-11-07 | 2009-08-18 | 더 제너럴 하스피탈 코포레이션 | Attenuation of vasoactive oxygen carrier-induced vasoconstriction |
US7928338B2 (en) * | 2007-02-02 | 2011-04-19 | Plasma Surgical Investments Ltd. | Plasma spraying device and method |
US20080193566A1 (en) * | 2007-02-09 | 2008-08-14 | Miller Christopher C | Use of high dose concentrations of gaseous nitric oxide |
CA2681308C (en) | 2007-03-23 | 2015-11-24 | Geno Llc | Conversion of nitrogen dioxide (no2) to nitric oxide (no) |
US10207927B2 (en) * | 2007-04-26 | 2019-02-19 | Ludlum Measurements, Inc. | Method to produce a calibration, reagent or therapeutic gas by exposing a precursor gas to ultraviolet light |
CN101828432B (en) | 2007-08-06 | 2013-11-06 | 普拉斯马外科投资有限公司 | Pulsed plasma device and method for generating pulsed plasma |
US7589473B2 (en) * | 2007-08-06 | 2009-09-15 | Plasma Surgical Investments, Ltd. | Pulsed plasma device and method for generating pulsed plasma |
US8735766B2 (en) * | 2007-08-06 | 2014-05-27 | Plasma Surgical Investments Limited | Cathode assembly and method for pulsed plasma generation |
EP2237788A4 (en) * | 2007-12-27 | 2013-06-05 | Aires Pharmaceuticals Inc | Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
WO2009097343A1 (en) * | 2008-01-28 | 2009-08-06 | Geno Llc | Conversion of nitrogen dioxide (no2) to nitric oxide (no) |
US8607785B2 (en) | 2008-08-21 | 2013-12-17 | Geno Llc | Systems and devices for generating nitric oxide |
DE102009013396B3 (en) * | 2009-03-16 | 2010-08-05 | Dräger Medical AG & Co. KG | Apparatus and method for controlling the oxygen dosage of a ventilator |
WO2010107744A1 (en) | 2009-03-16 | 2010-09-23 | Drexel University | Apparatus for atmospheric pressure pin-to-hole spark discharge and uses thereof |
WO2010151505A1 (en) | 2009-06-22 | 2010-12-29 | Geno Llc | Nitric oxide therapies |
US8646445B2 (en) * | 2009-11-20 | 2014-02-11 | Geno Llc | Nitric oxide delivery system |
US8613742B2 (en) * | 2010-01-29 | 2013-12-24 | Plasma Surgical Investments Limited | Methods of sealing vessels using plasma |
ES2873089T3 (en) * | 2010-02-01 | 2021-11-03 | Vero Biotech LLC | Nitric Oxide Delivery System |
JP5581500B2 (en) * | 2010-03-10 | 2014-09-03 | 学校法人北里研究所 | Treatment agent and treatment apparatus for reducing ischemia / reperfusion injury |
US9089319B2 (en) | 2010-07-22 | 2015-07-28 | Plasma Surgical Investments Limited | Volumetrically oscillating plasma flows |
GB201116271D0 (en) * | 2011-09-21 | 2011-11-02 | Univ Cardiff | Dispersion anaesthetic device |
EP2763935B2 (en) | 2011-10-03 | 2023-06-07 | NitricGen, Inc. | Apparatus and method for generating nitric oxide in controlled and accurate amounts |
WO2013070592A1 (en) | 2011-11-07 | 2013-05-16 | The General Hospital Corporation | Treatment of red blood cells |
US10426913B2 (en) | 2011-11-07 | 2019-10-01 | Mallinckrodt Hospital Products IP Limited | Apparatus and method for monitoring nitric oxide delivery |
JP2014532523A (en) | 2011-11-07 | 2014-12-08 | アイ・エヌ・オー セラピューティクス エル・エル・シーINO Therapeutics LLC | Apparatus and method for monitoring nitric oxide delivery |
US10449321B2 (en) | 2012-03-30 | 2019-10-22 | The Regents Of The University Of Michigan | Gas delivery devices |
US9498571B2 (en) * | 2012-03-30 | 2016-11-22 | The Regents Of The University Of Michigan | Nitric oxide delivery devices |
US9480785B2 (en) | 2012-03-30 | 2016-11-01 | The Regents Of The University Of Michigan | Nitric oxide delivery devices |
GB2517858A (en) * | 2012-05-30 | 2015-03-04 | David Bruce Crosbie | Nitric oxide generator and inhaler |
KR101308788B1 (en) * | 2012-12-13 | 2013-09-16 | 운해이엔씨(주) | A generation apparatus for nitrogen oxide of having a asepsis and odorless |
CA2905439A1 (en) * | 2013-03-13 | 2014-10-02 | Ino Therapeutics Llc | Devices and methods for monitoring oxygenation during treatment with delivery of nitric oxide |
AU2014228152B2 (en) | 2013-03-15 | 2018-07-05 | The General Hospital Corporation | Synthesis of nitric oxide gas for inhalation |
CN109663193A (en) | 2013-03-15 | 2019-04-23 | 通用医疗公司 | For the synthesis of the nitric oxide gas of sucking |
WO2014210030A2 (en) | 2013-06-25 | 2014-12-31 | Ino Therapeutics Llc | Methods of reducing the risk of mortality associated with a medical treatment |
CA2945724C (en) | 2013-10-24 | 2022-12-06 | Bsn Medical Gmbh | Immersion device |
JP6568519B2 (en) | 2013-11-07 | 2019-08-28 | ビーエスエヌ メディカル ゲーエムベーハー | Medical covering device |
RU2553290C1 (en) * | 2014-01-23 | 2015-06-10 | Российская Федерация, от имени которой выступает Государственная корпорация по атомной энергии "Росатом" | Nitrogen oxide generator system |
AU2015247710B2 (en) | 2014-04-15 | 2021-09-09 | Aobiome Llc | Ammonia-oxidizing Nitrosomonas eutropha strain D23 |
US11225640B2 (en) | 2014-04-15 | 2022-01-18 | Aobiome Llc | Ammonia oxidizing bacteria for treatment of psoriasis |
CN106660793B (en) | 2014-06-30 | 2020-05-01 | 奥里根股份有限公司 | Device for applying nitric oxide to a treatment site |
JP6947633B2 (en) * | 2014-10-20 | 2021-10-13 | ザ ジェネラル ホスピタル コーポレイション | Systems and methods for the synthesis of nitric oxide |
EP3020438A1 (en) | 2014-11-13 | 2016-05-18 | Linde AG | Device for ventilating a patient and method for operating a device for ventilating a patient |
RU2593297C2 (en) * | 2014-12-29 | 2016-08-10 | Российская Федерация, от имени которой выступает Государственная корпорация по атомной энергии "Росатом" | Method of producing gas mixture containing nitrogen oxide |
GB201500512D0 (en) * | 2015-01-13 | 2015-02-25 | Soe Health Ltd | Therapeutic treatment methods, and apparatus for use therein |
EP3053587A1 (en) | 2015-02-05 | 2016-08-10 | Linde AG | Combination of nitric oxide, helium and antibiotic to treat bacterial lung infections |
EP3108920A1 (en) | 2015-06-22 | 2016-12-28 | Linde AG | Device for delivering nitric oxide and oxygen to a patient |
KR20190014493A (en) | 2016-02-12 | 2019-02-12 | 말린크로트 하스피탈 프로덕츠 아이피 리미티드 | Use and monitoring of aspirated nitric oxide by left ventricular assist device |
CA3018379A1 (en) * | 2016-03-25 | 2017-09-28 | The General Hospital Corporation | Delivery systems and methods for electric plasma synthesis of nitric oxide |
AU2017370741A1 (en) * | 2016-12-09 | 2019-06-20 | Microdose Therapeutx, Inc. | Inhaler |
CN110114307B (en) | 2016-12-14 | 2022-09-23 | 欧利景有限公司 | Apparatus and method for producing high concentration, low temperature nitric oxide |
JP6704094B2 (en) | 2017-02-27 | 2020-06-03 | サード ポール, インコーポレイテッドThird Pole, Inc. | System and method for producing nitric oxide |
MX2020010523A (en) * | 2017-02-27 | 2021-02-09 | Third Pole Inc | Systems and methods for generating nitric oxide. |
KR20220137155A (en) * | 2017-02-27 | 2022-10-11 | 써드 폴, 아이엔씨. | Systems and methods for ambulatory generation of nitric oxide |
KR20210064346A (en) * | 2018-09-27 | 2021-06-02 | 더 리젠츠 오브 더 유니버시티 오브 미시건 | gas delivery devices |
EP3871728A4 (en) | 2018-10-25 | 2022-08-03 | Teijin Pharma Limited | Relay administration device and nitrogen monoxide administration system |
US20210316108A1 (en) | 2018-10-25 | 2021-10-14 | Teijin Pharma Limited | Nitric oxide administration device |
KR102571301B1 (en) | 2018-10-25 | 2023-08-25 | 데이진 화-마 가부시키가이샤 | Nitric Oxide Dosing Device |
EP3969415A4 (en) | 2019-05-15 | 2023-08-16 | Third Pole, Inc. | Electrodes for nitric oxide generation |
WO2020232419A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Systems and methods for generating nitric oxide |
JP2023512444A (en) | 2020-01-11 | 2023-03-27 | サード ポール,インコーポレイテッド | Systems and methods for nitric oxide generation using humidity control |
US20230201514A1 (en) * | 2020-06-05 | 2023-06-29 | The General Hospital Corporation | Systems and methods for nitric oxide generation and treatment |
US20210395905A1 (en) | 2020-06-18 | 2021-12-23 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
KR102227464B1 (en) * | 2020-08-03 | 2021-03-12 | 한국핵융합에너지연구원 | Method and Apparatus for Controlling NOx and Method for Preparing NOx-Containing Water |
US11975139B2 (en) * | 2021-09-23 | 2024-05-07 | Third Pole, Inc. | Systems and methods for delivering nitric oxide |
WO2023075629A1 (en) * | 2021-10-27 | 2023-05-04 | Федеральное государственное унитарное предприятие "Российский федеральный ядерный центр - Всероссийский научно-исследовательский институт экспериментальной физики" | Device for producing nitric oxide |
KR20230075679A (en) * | 2021-11-23 | 2023-05-31 | 한국핵융합에너지연구원 | High-purity no2 gas generator and high-concentration activated water and fertilizer water manufacturing device based on nitrate using plasma |
CN114348979A (en) * | 2021-12-31 | 2022-04-15 | 陕西聚能新创煤化科技有限公司 | NO gas production system and production method based on plasma ionization heating device |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4336798A (en) * | 1980-10-06 | 1982-06-29 | Anthony V. Beran | Medical corrugated respiratory tube |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3785377A (en) * | 1970-11-12 | 1974-01-15 | S Jorgensen | Plant, preferably for anaesthesia |
US4010897A (en) * | 1976-03-31 | 1977-03-08 | Charles F. Kettering Foundation | Method and apparatus for home production and application of nitrogen fertilizer |
IL57239A (en) * | 1979-05-08 | 1982-04-30 | Alamaro Moshe | Production of nitric oxides |
US4297123A (en) * | 1980-02-07 | 1981-10-27 | Wyse Harold G | Method and apparatus for producing a nitrate fertilizer |
US4877589A (en) * | 1988-09-19 | 1989-10-31 | Hare Louis R O | Nitrogen fixation by electric arc and catalyst |
US4915915A (en) * | 1988-10-11 | 1990-04-10 | Treharne Richard W | Water-powdered piezoelectric unit for producing nitrogen fertilizer |
-
1992
- 1992-03-11 US US07/850,383 patent/US5396882A/en not_active Expired - Lifetime
-
1993
- 1993-03-08 PT PT93908422T patent/PT630270E/en unknown
- 1993-03-08 AT AT93908422T patent/ATE242022T1/en active
- 1993-03-08 BR BR9306060A patent/BR9306060A/en not_active IP Right Cessation
- 1993-03-08 DK DK93908422T patent/DK0630270T3/en active
- 1993-03-08 WO PCT/US1993/002518 patent/WO1993017741A1/en active IP Right Grant
- 1993-03-08 ES ES93908422T patent/ES2196006T3/en not_active Expired - Lifetime
- 1993-03-08 CA CA002117691A patent/CA2117691C/en not_active Expired - Fee Related
- 1993-03-08 DE DE69333015T patent/DE69333015T2/en not_active Expired - Lifetime
- 1993-03-08 AU AU39250/93A patent/AU3925093A/en not_active Abandoned
- 1993-03-08 JP JP51606693A patent/JP3573455B2/en not_active Expired - Fee Related
- 1993-03-08 EP EP93908422A patent/EP0630270B1/en not_active Expired - Lifetime
- 1993-03-11 MX MX9301357A patent/MX9301357A/en unknown
- 1993-09-09 TW TW082107415A patent/TW242117B/zh active
-
1994
- 1994-09-09 FI FI944170A patent/FI110922B/en not_active IP Right Cessation
- 1994-09-09 NO NO19943349A patent/NO310961B1/en not_active IP Right Cessation
-
2004
- 2004-03-17 JP JP2004077201A patent/JP3792701B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4336798A (en) * | 1980-10-06 | 1982-06-29 | Anthony V. Beran | Medical corrugated respiratory tube |
Non-Patent Citations (1)
Title |
---|
Ind. Eng. Chem. Funden., 1977, Vol. 16, No. 2, (DONOHOE et al.), "Production of O3,NO and N2O in a Pulsed Discharge at 1 Atm", pages 208-215, see fig 1; p. 209, col. 1, line 7; p. 211, col. 1, line 11 and lines 45-46. * |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2283179A (en) * | 1993-10-12 | 1995-05-03 | Timothy William Higenbottam | Apparatus for nitric oxide treatment |
GB2283179B (en) * | 1993-10-12 | 1997-12-10 | Timothy William Higenbottam | Nitric oxide treatment |
WO2000030659A1 (en) * | 1998-11-23 | 2000-06-02 | Pulmonox Medical Corporation | Method and apparatus for treatment of respiratory infections by nitric oxide inhalation |
EP1046405B1 (en) * | 1999-04-24 | 2004-06-23 | Klaus Büttner | Aerosol nebulizer |
US6793644B2 (en) | 2000-12-26 | 2004-09-21 | Sensormedics Corporation | Device and method for treatment of surface infections with nitric oxide |
WO2009093169A1 (en) * | 2008-01-22 | 2009-07-30 | Koninklijke Philips Electronics N.V. | Device for the topical delivery of nitric oxide to a skin surface |
US10780241B2 (en) | 2008-08-21 | 2020-09-22 | Vero Biotech LLC | Devices and methods for minimizing and treating high-altitude sickness |
US8821828B2 (en) | 2009-12-23 | 2014-09-02 | Koninklijke Philips N.V. | Method for generating nitric oxide |
US11607520B2 (en) | 2010-04-26 | 2023-03-21 | Vero Biotech Inc. | Delivery of ultra pure nitric oxide (NO) |
US9457049B2 (en) | 2010-09-22 | 2016-10-04 | Konklijke Philips N.V. | Method for generating nitric oxide |
WO2015066278A1 (en) * | 2013-10-31 | 2015-05-07 | Advanced Plasma Therapies, Inc. | Methods for using nitric oxide in a plasma state to treat medical conditions and diseases |
CN105473166A (en) * | 2013-10-31 | 2016-04-06 | 奥里根股份有限公司 | Methods for using nitric oxide in a plasma state to treat medical conditions and diseases |
EP3398618A1 (en) * | 2013-10-31 | 2018-11-07 | Origin, Inc. | Methods for forming a discrete steam of matter in a plasma state |
WO2015191843A1 (en) * | 2014-06-13 | 2015-12-17 | Advanced Plasma Therapies, Inc. | Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals |
EP3154554A4 (en) * | 2014-06-13 | 2018-02-07 | Origin, Inc. | Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals |
CN106604735A (en) * | 2014-06-13 | 2017-04-26 | 奥里根股份有限公司 | Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals |
EP3609509A4 (en) * | 2017-03-31 | 2020-11-25 | The General Hospital Corporation | Systems and methods for a cooled nitric oxide generator |
US11951261B2 (en) | 2018-10-25 | 2024-04-09 | Teijin Pharma Limited | Nitric oxide administration device |
WO2022265837A1 (en) * | 2021-06-17 | 2022-12-22 | Origin, Inc. | Methods of using a plasma-generated stream of no-containing gas for treatment of a spectrum of medical conditions |
Also Published As
Publication number | Publication date |
---|---|
PT630270E (en) | 2003-09-30 |
CA2117691A1 (en) | 1993-09-16 |
EP0630270A4 (en) | 1995-04-19 |
FI110922B (en) | 2003-04-30 |
NO943349D0 (en) | 1994-09-09 |
JPH07505073A (en) | 1995-06-08 |
BR9306060A (en) | 1997-11-18 |
ES2196006T3 (en) | 2003-12-16 |
MX9301357A (en) | 1994-04-29 |
DE69333015T2 (en) | 2004-04-01 |
TW242117B (en) | 1995-03-01 |
AU3925093A (en) | 1993-10-05 |
NO310961B1 (en) | 2001-09-24 |
FI944170A0 (en) | 1994-09-09 |
JP3573455B2 (en) | 2004-10-06 |
NO943349L (en) | 1994-11-10 |
US5396882A (en) | 1995-03-14 |
CA2117691C (en) | 2006-05-09 |
DK0630270T3 (en) | 2003-06-23 |
EP0630270B1 (en) | 2003-06-04 |
JP3792701B2 (en) | 2006-07-05 |
FI944170A (en) | 1994-09-09 |
DE69333015D1 (en) | 2003-07-10 |
ATE242022T1 (en) | 2003-06-15 |
JP2004167284A (en) | 2004-06-17 |
EP0630270A1 (en) | 1994-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5396882A (en) | Generation of nitric oxide from air for medical uses | |
AU2020256426B2 (en) | Systems and methods for the synthesis of nitric oxide | |
CN1099997A (en) | Generation of nitric oxide from air for medical uses | |
JP6968192B2 (en) | Systems and methods for cooled nitric oxide generators | |
EP1365778B1 (en) | Treating pulmonary disorders with gaseous agent causing repletion of gsno | |
US7700135B2 (en) | Cerebral protection with a xenon-containing gas | |
EP1558312B1 (en) | Therapeutic agent delivery device and method | |
US7299802B2 (en) | Carbon dioxide delivery apparatus and method for using same | |
US7235264B2 (en) | Cerebral protection with a gas comprising xenon | |
GB2320900A (en) | Inhalers | |
JP2003000714A (en) | Air supply device for breathing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR CA CH CZ DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2117691 Country of ref document: CA Ref document number: 944170 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993908422 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993908422 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 944170 Country of ref document: FI |
|
WWG | Wipo information: grant in national office |
Ref document number: 1993908422 Country of ref document: EP |